BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive LeukemiaMatthew S. Zabriskie, Thomas O’Hare, Kimberly R. Reynolds et al.|Cancer Cell|2014Cited by 366
Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinibAndreas Hochhaus, H. Kantarjian, Michele Baccarani et al.|Leukemia|2008Cited by 354
Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological MalignanciesArjun Law, Auro Viswabandya, María Queralt Salas et al.|Biology of Blood and Marrow Transplantation|2018Cited by 92
Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHDMaría Queralt Salas, Auro Viswabandya, Shruti Prem et al.|Bone Marrow Transplantation|2020Cited by 59
Pilot prospective study of Frailty and Functionality in routine clinical assessment in allogeneic hematopoietic cell transplantationMaría Queralt Salas, Rajat Kumar, Eshetu G. Atenafu et al.|Bone Marrow Transplantation|2020Cited by 43